| Citation: |
CHEN Cheng, SU Danyan, QIN Suyuan, HUANG Yuqin, YE Bingbing, HUANG Yanyun, PANG Yusheng. Gene mutation and clinical characteristics of dilated cardiomyopathy in children[J]. Journal of Guangxi Medical University, 2025, 42(1): 108-113. DOI: 10.16190/j.cnki.45-1211/r.2025.01.014
|
To analyze the gene mutation and clinical characteristics of idiopathic dilated cardiomyopathy (DCM) in children.
The results of genetic testing and clinical data of 27 children with DCM treated in the First Affiliated Hospital of Guangxi Medical University from June 2015 to July 2021 were collected. The patients were grouped according to results of genetic testing, the clinical characteristics of the two groups were compared, and the gene mutation and prognosis were explored.
There were 27 cases of children with DCM, including 16 cases of male and 11 cases of female, ranging from 0.3 to 13.7 years old, with an average age of (8.5±4.4) years. A total of 13 cases were positive for genetic mutation, accounting for 48.1% (13/ 27). There were no significant differences in the proportion of annual NYHA class Ⅲ/Ⅳ, left ventricular enddiastolic diameter, left ventricular ejection fraction, and mortality between the two groups (P > 0.05). A total of 62 mutation sites were found in 22 kinds of gene mutations in 27 children, among which TTN was 21, accounting for the highest proportion (33.8%). The average follow-up time was (19.3±17.9) months, and 15 cases died, with a mortality rate of 55.5% (15/27). Six cases died in the mutation-positive group, including two cases of TPM1 gene. DMD, DSP, TNNI and TTN genes were found in one case each.
The mortality rate is high in children with definite genetic pathogenicity. There is no statistically significant correlation between positive gene mutation and the severity of DCM in children at the first diagnosis as well as the prognosis of children with DCM.
| [1] |
LIPSHULTZ S E, LAW Y M, ASANTE-KORANG A, et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American heart association [J]. Circulation, 2019, 140(1): e9-e68.
|
| [2] |
ELDEMIRE R, MESTRONI L, TAYLOR M R G. Genetics of dilated cardiomyopathy [J]. Annual review of medicine, 2024, 75: 417-426. doi: 10.1146/annurev-med-052422-020535
|
| [3] |
REZA N, DE FERIA A, CHOWNS J L, et al. Cardiovascular characteristics of patients with genetic variation in desmoplakin (DSP) [J]. Cardiogenetics, 2022, 12(1): 24-36. doi: 10.3390/cardiogenetics12010003
|
| [4] |
CRASTO S, MY I, DI PASQUALE E. The broad spectrum of lmna cardiac diseases: from molecular mechanisms to clinical phenotype [J]. Frontiers in physiology, 2020, 11: 761. doi: 10.3389/fphys.2020.00761
|
| [5] |
LEE J TERMGLINCHAN N, DIECKE S, et al. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy [J]. Nature, 2019, 572(7769): 335-340. doi: 10.1038/s41586-019-1406-x
|
| [6] |
UJIHARA Y, KANAGAWA M, MOHRI S, et al. Elimination of fukutin reveals cellular and molecular pathomechanisms in muscular dystrophy-associated heart failure [J]. Nature communications, 2019, 10(1): 5754. doi: 10.1038/s41467-019-13623-2
|
| [7] |
RJCHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology[J]. Genetics in medicine, 2015, 17(5): 405-424. doi: 10.1038/gim.2015.30
|
| [8] |
PETROPOULOU E, SOLTANI M, FIROOZABADI A D, et al. Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy [J]. European journal of medical genetics, 2017, 60(9): 485-488. doi: 10.1016/j.ejmg.2017.06.008
|
| [9] |
GAERTNER A, BLOEBAUM J, BRODEHL A, et al. The combined human genotype of truncating TTN and RBM20 mutations is associated with severe and early onset of dilated cardiomyopathy[J]. Genes, 2021, 12(6): 883. doi: 10.3390/genes12060883
|
| [10] |
ZAKLYAZMINSKAYA E, MIKHAILOV V, BUKAEVA A, et al. Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy-a pilot study [J]. Scientific reports, 2019, 9(1): 16409. doi: 10.1038/s41598-019-52911-1
|
| [11] |
ROBERTS A M, WARE J S, HERMAN D S, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease [J]. Science translational medicine, 2015, 7(270): 270ra6.
|
| [12] |
AKHTAR M M, LORENZINI M, CICERCHIA M, et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene [J]. Circulation heart failure, 2020, 13(10): e006832.
|
| [13] |
LAKDAWALA N K, DELLEFAVE L, REDWOOD C S, et al. Familial dilated cardiomyopathy caused by an alphatropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy [J]. Journal of the american college of cardiology, 2010, 55(4): 320-329. doi: 10.1016/j.jacc.2009.11.017
|
| [14] |
WANG D F, LYU J L, FANG J, et al. Impact of LDB3 gene polymorphisms on clinical presentation and implantable cardioverter defibrillator (ICD) implantation in Chinese patients with idiopathic dilated cardiomyopathy [J]. Journal of Zhejiang university science B, 2019, 20(9): 766-775. doi: 10.1631/jzus.B1900017
|
| [15] |
LAW M L, COHEN H, MARTIN A A, et al. Dysregulation of calcium handling in duchenne muscular dystrophyassociated dilated cardiomyopathy: mechanisms and experimental therapeutic strategies [J]. Journal of clinical medicine, 2020, 9(2): 520. doi: 10.3390/jcm9020520
|
| [16] |
VILLARREAL-MMOLINA M T, ROSAS-MADRIGAL S, LóPEZ-MORA E, et al. Homozygous fukutin missense mutation in two mexican siblings with dilated cardiomyopathy [J]. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2020, 73(5).
|
| [17] |
ORTIZ-GENGA M F, CUENCA S, DAL FERRO M, et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies [J]. Journal of the American college of cardiology, 2016, 68(22): 2440-2451. doi: 10.1016/j.jacc.2016.09.927
|
| [18] |
ELLIOTT P, O'MAHONY C, SYRRIS P, et al. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy [J]. Circulationcardiovascular genetics, 2010, 3(4): 314-322. doi: 10.1161/CIRCGENETICS.110.937805
|
| [19] |
BHUIYAN Z A, VAN DEN BERG M P, VAN TINTELEN J P, et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features [J]. Circulation, 2007, 116(14): 1569-1576. doi: 10.1161/CIRCULATIONAHA.107.711606
|
| [20] |
AL-SAAIDI R A, RASMUSSEN T B, BIRKLER R I D, et al. The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope [J]. European journal of heart failure, 2018, 20(10): 1404-1412. doi: 10.1002/ejhf.1241
|
| [21] |
FERRADINI V, COSMA J, ROMEO F, et al. Clinical features of LMNA-related cardiomyopathy in 18 patients and characterization of two novel variants [J]. Journal of clinical medicine, 2021, 10(21): 5075. doi: 10.3390/jcm10215075
|
| [22] |
VAN DEN HOOGENHOF M M G, BEQQALI A, AMIN A S, et al. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling [J]. Circulation, 2018, 138(13): 1330-1342. doi: 10.1161/CIRCULATIONAHA.117.031947
|
| [23] |
PETERS S, THOMPSON B A, PERRIN M, et al. Arrhythmic phenotypes are a defining feature of dilated cardiomyopathy-associated SCN5A variants: A systematic review [J]. Circulation-genomic and precision medicine, 2022, 15(1): e003432.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: